ImmunityBio, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
IBRX on Nasdaq
Location
3530 John Hopkins Court, San Diego, CA

There are no Buy or Sell transactions made by insiders since 12/2/2024

ImmunityBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick Soon Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner $241M Feb 22, 2025
Barry J. Simon Director $11.2M Feb 22, 2025
Richard Adcock CEO & President, Director $2.19M Feb 22, 2025
John C. Thomas Former Director $1.09M Dec 31, 2021
David C. Sachs Chief Financial Officer $1.05M Feb 22, 2025
Regan J. Lauer Chief Accounting Officer $405K Feb 22, 2025
Linda Maxwell Director Jun 18, 2025
Christobel Selecky Director Jun 18, 2025
Wesley Clark Director Jun 18, 2025
John Owen Brennan Director Jun 11, 2024
Michael D. Blaszyk Director Jun 18, 2025
Cheryl Cohen Director Jun 18, 2025

Recent Insider Transactions by Companies or Individuals for ImmunityBio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.